Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels are nonselective voltage-gated cation channels primarily found in heart and brain cells. They are encoded by four genes (HCN1-4) and play a crucial role in controlling rhythmic electrical activity, such as cardiac pacemaking and neuronal excitability. HCN channels activate upon hyperpolarization and are further modulated by intracellular cyclic nucleotides (cAMP, cGMP, cCMP). Dysfunction of HCN channels is implicated in cardiac arrhythmias and neurological disorders, making them a therapeutic target for conditions like bradycardia, epilepsy, neuropathic pain, and depression.
Inhibition of HCN channel activity
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hyperpolarization-Activated Cyclic Nucleotide-Gated Cation Channel (HCN).